HTLV-1 p30II AND p12 PROTEINS AS THERAPEUTIC TARGETS IN HTLC-1 INFECTED INDIVIDUALS
Technology
E-173-2001
Patent ID
E-173-2001-0-US-01
Country
US
Application Type
Patent Status
Abandoned
Patent Number
Publication Number
Application Number
60/404,580
IC
NCI
Date Filed
Date Issued
Patent PDF